Filter Results:
(990)
Show Results For
- All HBS Web
(990)
- People (4)
- News (256)
- Research (615)
- Events (9)
- Multimedia (24)
- Faculty Publications (396)
Show Results For
- All HBS Web
(990)
- People (4)
- News (256)
- Research (615)
- Events (9)
- Multimedia (24)
- Faculty Publications (396)
- 27 Feb 2018
- First Look
First Look at New Research and Ideas, February 27, 2018
company. Purchase this case: https://cb.hbsp.harvard.edu/cbmp/product/718403-PDF-ENG Harvard Business School Case 618-033 BeiGene BeiGene was a biopharmaceutical company founded on exploiting a temporal regulatory policy discontinuity. Because of regulatory challenges... View Details
Keywords: Sean Silverthorne
- 16 Oct 2013
- Op-Ed
Response to Readers: Combating Climate Change with Nuclear Power and Fracking
With more than 7,500 views and 180-plus tweets, I want to thank everyone for taking the time to read the original HBS Working Knowledge piece, The Case for Combating Climate Change with Nuclear Power and Fracking, and, in particular, for sharing your thoughts with one... View Details
- 12 Feb 2019
- First Look
New Research and Ideas, February 12, 2019
Devices: Challenges and Opportunities for U.S. Regulators and Innovators By: Gordon, William J., and Ariel Dora Stern Abstract— Software has become an increasingly important component of medical device technology. Through legislation like the 21st Century Cures Act as... View Details
Keywords: Dina Gerdeman
- 27 Mar 2012
- First Look
First Look: March 27
services will become its key competitive advantage in the decade to come. This case traces the evolution of the CRO sector from a small, secondary cluster of firms into a major player with essential capabilities for global drug... View Details
Keywords: Carmen Nobel
- 17 Oct 2006
- First Look
First Look: October 17, 2006
founded by a young venture capitalist and a university professor to exploit recombinant DNA technology. Thirty years and more than $300 billion in investments later, only a handful of biotech firms have matched Genentech's success or even shown a profit. No avalanche... View Details
Keywords: Sean Silverthorne
- 12 Jul 2006
- Research & Ideas
Competition the Cure for Healthcare
the various actors in the system are not designed around value, nor is competition reinforcing improvements in value. For example, let's take the prescription drug benefit, the big reform of today that everyone is talking about. This is... View Details
- 19 Jun 2013
- Research & Ideas
Analyzing Institutions to Solve Big Problems
that marijuana was a popular treatment in the nineteenth century, and the drug was listed in the Dispensatory of the United States by the 1850s. The paper looks at how the Federal Bureau of Narcotics managed not only to illegalize the... View Details
Keywords: by Carmen Nobel & Anna Secino
- 19 Jun 2020
- Blog Post
Black MBA Students Pen Letters to the HBS Community: Letter 5/5
socioeconomic background. I have seen communities plagued with poor education systems and I have seen, how mental health-induced drug abuse is treated as a crime. I have witnessed Black adults frantically afraid when pulled over by the... View Details
- 27 Nov 2017
- Research & Ideas
Beware the Lasting Impression of a 'Temporary' Selfie
a prop, or exhibited nudity, drinking, or drug use. As to the impact on observers of the posts, the temporary-sharers were characterized as having worse judgment than those who shared in permanent mediums. That belief was underscored... View Details
Keywords: by Rachel Layne
- 01 Sep 2004
- News
A Market-Based Prescription
change? Congress has already passed a piece of legislation that is tremendously important to the consumer-driven movement. Health savings accounts, established as part of the Medicare prescription drug bill in 2003, will allow the... View Details
- 24 Mar 2020
- Research & Ideas
These Coronavirus Heroes Show Us How Crisis Leadership Works
American manufacturer of antibiotics—those life-saving drugs required for pneumonia caused by COVID-19—as others have abandoned them to pursue more lucrative drugs. Frazier elected to stay in the business because he knows how essential... View Details
- 01 Mar 2015
- News
In My Humble Opinion: Leonard Dick (MBA 1990)
it’s not drug problems or throwing a stapler at the assistant. It’s missing a delivery date. A veteran I worked with told me, ‘Your job isn’t to make it great; your job is to get it in by Tuesday.’ ” Dick’s prime-time résumé includes The... View Details
- 18 Nov 2014
- First Look
First Look: November 18
innovative drug candidates for testing in patients. Project teams consisted of Pfizer scientists and academics working side-by-side to reduce the time needed to bring a therapeutic drug from the lab to a... View Details
Keywords: Sean Silverthorne
- 02 Sep 2008
- First Look
First Look: September 3, 2008
Note on Generic Drugs in the European Union Harvard Business School Note 309-019 Rules governing the introduction of generic drugs in U.S. and EU have some similarities but significant differences because of... View Details
Keywords: Sean Silverthorne
- Web
Student Spotlight: From Nigeria to HBS: Reigniting My Passion for Healthcare Innovation - Blog: Health Supplement
incredible opportunity to work on an independent project focused on commercializing a drug therapy. It’s exactly the kind of hands-on, impactful work I came to HBS to pursue, and I’m thrilled to be diving into it. Without HBS, I wouldn’t... View Details
- Web
Drone Policy | About
under the influence of alcohol or while using any drug that could adversely affect the pilot’s ability to safely control the aircraft. Aircraft cannot be operated carrying pyrotechnic devices that explode or burn, or any device which... View Details
- Web
1.19 Immersive Field Courses (IFC) | MBA
right to modify the course or deny a student’s choice of location(s) for coursework participation, whichever is the least-restrictive reasonable alternative. Drug & Alcohol Policy The HBS Drug & Alcohol... View Details
- 03 Mar 2009
- First Look
First Look: March 3, 2009
Public Interest: Roche & Tamiflu Harvard Business School Case 609-061 The case focuses on the challenges of Roche maintaining a supply network for a global influenza pandemic response initiative based on its antiviral drug Tamiflu.... View Details
Keywords: Martha Lagace
- 31 May 2016
- First Look
May 31, 2016
significant investment in bio-similars as a way to differentiate itself from its generic drug industry peers, has to negotiate with its parent company and the innovative pharma division on how best to commercialize its bio-similar... View Details
Keywords: Sean Silverthorne
- 08 Jun 2010
- First Look
First Look: June 8
case:http://cb.hbsp.harvard.edu/cb/product/810123-PDF-ENG Myelin Repair Foundation: Accelerating Drug Discovery Through Collaboration Karim R. Lakhani and Paul R. CarlileHarvard Business School Case 610-074 This case presents the Myelin... View Details
Keywords: Martha Lagace